Docetaxel enhances the cytotoxicity of anthracyclines by increasing intracellular drug accumulation

Tomohisa Egawa, Tetsuro Kubota, Akihiko Suto, Yoshihide Otani, Toshiharu Furukawa, Masahiko Watanabe, Koichiro Kumai, Masaki Kitajima

研究成果: Article

3 引用 (Scopus)

抜粋

We assessed the combined antitumor activity of docetaxel and doxorubicin (DXR) and tetrahydropyranyladriamycin (THP) using the human breast carcinoma cell lines R-27 and MDA-MB-231. Synergistic antitumor activity was observed for both combined docetaxel and DXR, and docetaxel and THP against R-27 cells when contacted simultaneously. However, only additive effects were observed against MDA-MB-231 cells. Intracellular concentrations of DXR and THP in R-27 cells were significantly increased by docetaxel pretreatment, however, this increase was not observed in MDA-MB-231 cells, which exhibited only additive sensitivity to the treatment. Thus, docetaxel increased the antitumor activity of anthracyclines by increasing their intracellular concentrations.

元の言語English
ページ(範囲)777-781
ページ数5
ジャーナルOncology reports
9
発行部数4
DOI
出版物ステータスPublished - 2002 7

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

フィンガープリント Docetaxel enhances the cytotoxicity of anthracyclines by increasing intracellular drug accumulation' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Egawa, T., Kubota, T., Suto, A., Otani, Y., Furukawa, T., Watanabe, M., Kumai, K., & Kitajima, M. (2002). Docetaxel enhances the cytotoxicity of anthracyclines by increasing intracellular drug accumulation. Oncology reports, 9(4), 777-781. https://doi.org/10.3892/or.9.4.777